SBN sun biomedical limited

despatch of rights issue, page-14

  1. 3,715 Posts.
    The big thing Vin will be the benchmark set through successful testing.

    OraLine will be shown to be:

  2. Easy to use
  3. Non invasive
  4. Accurate
  5. Relatively inexpensive

    There will no doubt be a government funded study (possibly a PhD thesis) on its inception and reception among schools and its effects.

    Positive use through that sort of environment will set Sun up for years.

    Cheers



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.